Park Ha Biological Technology Co., Ltd., a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, announced the closing of its initial public offering of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share.WHO: Established in 2016 and headquartered in Wuxi, Jiangsu Province, Park Ha Biological Technology Co.'s main business includes proprietary skincare brands, direct sales of skincare products, and franchising services. Among these, the brand Park Ha was founded in 2016 and opened its first store in 2017, dedicated to providing solutions for consumer skincare concerns. The company has two directly operated stores and 43 franchisees, of which 41 and 2 operate under the store name Park Ha and Geni, respectively, in China.DETAILS:Park Ha Biological Technology Co., Ltd. closed an IPO of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share.The ordinary shares began trading on the Nasdaq Capital Market on December 27, 2024, under the ticker symbol “PHH.”The company received aggregate gross proceeds of $4.8 million from the offering,In addition, the company has granted the underwriters a 45-day option to purchase up to 180,000 additional ordinary shares, representing 15% of the ordinary shares sold in the offering, at the public offering price, less underwriting discounts.According to the prospectus, Park Ha Bio conducts its business through three domestic operating entities: Jiangsu Park Ha Bio Technology Co., Ltd., Wuxi Xinzhan Enterprise Management Consulting Co., Ltd., and Shanghai Park Ha Industrial Development Co., Ltd.